Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Prognosis of Korean Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy(CADASIL) Patients: A Multicenter Prospective Study

NCT07497867 is registered in ClinicalTrials.gov with Jeju National University Hospital as lead sponsor.

NCT NCT07497867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07497867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Prognosis of Korean Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy(CADASIL) Patients: A Multicenter Prospective Study
Lead sponsor
Jeju National University Hospital
Phase
Observational
Overall status
Recruiting
Start date
July 10, 2023
Completion date
December 31, 2040
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cadasil, cerebral autosomal dominant arteriopatie with subcortical infarcts and leukoencephalopathy